The Cancer Gene Panel and Profiling Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors. Expert reviews of competitor strategies and recent developments provide a clearer view of regional dynamics and future market trajectories, establishing a strong foundation for strategic planning and informed investment decisions.
What will be the market size of Cancer Gene Panel and Profiling market 2029?
The Global Cancer Gene Panel & Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29.
Download Free PDF Brochure: https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html
Who are the top companies operating in the Cancer Gene Panel and Profiling market?
The report features prominent companies operating in the Cancer Gene Panel and Profiling market and the successful strategies they have adopted. It also provides detailed insights into each company’s market share and their role in driving the industry’s growth. As per MarkNtel Advisors, top companies in Cancer Gene Panel and Profiling market: 10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other.
What is the key factor projected to fuel growth in the Cancer Gene Panel and Profiling Market between 2024 and 2029?
Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.
Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:
- In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.
Cancer Gene Panel and Profiling Market - Segmentation Analysis
- By Technology (Next-generation Sequencing [NGS], Polymerase Chain Reaction [PCR], Microarray, Mass Spectrometry, Others)
- By Application (Oncology Research, Personalized Medicine, Drug Development, Clinical Diagnostics)
- By Cancer Type (Breast Cancer, Lung Cancer, Prostrate Cancer, Colorectal Cancer, Others) , By Cell Type (Germline, Somatic)
- By End-User (Hospital & Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical and Biotechnology)
- By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific),
- By Company (10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies,, Other
Browse Full Research Report: https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html
How does the Cancer Gene Panel and Profiling Market vary across different geography?
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
North America held the largest share in the Global Cancer Gene Panels and Profiling Market.
This Section cover detailed analysis of revenue, market share and growth rate, historical data (2019-22) and forecast (2024-2029) of the following segmentation and geography.
Inquire Before Buying, Connect with our Expertise Today: https://www.marknteladvisors.com/query/talk-to-our-consultant/cancer-gene-panel-profiling-market.html
Comprehensive Table of Contents – Cancer Gene Panel and Profiling Market Analysis and Forecast, 2029
- Table 1: Introduction
- Table 2: Executive Summary
- Table 3: Market Regulations, Policies & Standards
- Table 4: Cancer Gene Panel and Profiling Market Size, Share & Scope, 2020-2029F
- Table 5: Market Trends & Developments
- Table 6: Market Dynamics (Key Drivers, and Challenges)
- Table 7: Market Hotspots & Opportunities
- Table 8: Market Value Chain Analysis
- Table 9: Market Outlook, 2020-2029F
- Table 10: Market Size & Analysis by Revenues (USD Million):
- Table 11: Market Size & Forecast 2020–2029 by Segmentation
- Table 12: Market Size & Forecast 2020–2029 by Geography
- Table 13: Key Strategic Imperatives for Success & Growth
- Table 14: Competitor Analysis of Cancer Gene Panel and Profiling Companies
Key Benefits for Industry Participants and Stakeholders
- Insight into emerging market trends and investment opportunities
- Understanding of regional market dynamics and competitive landscapes
- Data-driven forecasts to support strategic decision-making
- Access to industry benchmarks for performance evaluation
- Identification of potential risks and growth challenges
Browse More Reports:
- Thermal Interface Materials Market Research Report: Forecast (2024-2030)
- Global Welding Gas Market Research Report: Forecast (2024-2030)
About Us:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
